Halyard Health (HYH) Misses Q4 EPS by 23c, Offers FY17 Guidaance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Halyard Health (HYH) PT Raised to $45 at Stifel Following 4Q Beat
February 28, 2017 9:56 AM ESTStifel raised its price target on Halyard Health (NYSE: HYH) to $45.00 (from $38.00) while maintaining a Buy rating. 4Q16 EPS at $0.50 beat Stifel ($0.46) and Consensus ($0.44) estimates though a one-time tax benefit added ~$0.04.
Analyst Rick Wise commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015)... More
